Session

H. pylori: From disease pathway to therapy

EFFECTIVENESS OF HELICOBACTER PYLORI TREATMENTS ACCORDING TO ANTIBIOTIC RESISTANCE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF HELICOBACTER PYLORI TREATMENTS ACCORDING TO ANTIBIOTIC RESISTANCE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori: From disease pathway to therapy  et al.

EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

H. pylori: From disease pathway to therapy  et al.

IMPACT OF PROBIOTICS USE ON THE SAFETY OF HELICOBACTER PYLORI TREATMENTS: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
IMPACT OF PROBIOTICS USE ON THE SAFETY OF HELICOBACTER PYLORI TREATMENTS: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

H. pylori: From disease pathway to therapy  et al.

HELICOBACTER PYLORI PROMOTES DNA DAMAGE AND INHIBITS TUMOR PROLIFERATION AND MIGRATION THROUGH THE ACVR1-IRF3-POLD1 SIGNALING AXIS
HELICOBACTER PYLORI PROMOTES DNA DAMAGE AND INHIBITS TUMOR PROLIFERATION AND MIGRATION THROUGH THE ACVR1-IRF3-POLD1 SIGNALING AXIS

H. pylori: From disease pathway to therapy  et al.

CHARACTERISTIC MICROBIAL ENTEROTYPES AND STOMATOTYPES INCREASE THE RISK OF HELICOBACTER PYLORI INFECTION WITHIN COHABITING FAMILY MEMBERS
CHARACTERISTIC MICROBIAL ENTEROTYPES AND STOMATOTYPES INCREASE THE RISK OF HELICOBACTER PYLORI INFECTION WITHIN COHABITING FAMILY MEMBERS

H. pylori: From disease pathway to therapy  et al.

EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL SECOND-LINE TREATMENTS IN EUROPE: RESULTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

CHARACTERISTIC MICROBIAL ENTEROTYPES AND STOMATOTYPES INCREASE THE RISK OF HELICOBACTER PYLORI INFECTION WITHIN COHABITING FAMILY MEMBERS
CHARACTERISTIC MICROBIAL ENTEROTYPES AND STOMATOTYPES INCREASE THE RISK OF HELICOBACTER PYLORI INFECTION WITHIN COHABITING FAMILY MEMBERS

IMPACT OF PROBIOTICS USE ON THE SAFETY OF HELICOBACTER PYLORI TREATMENTS: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
IMPACT OF PROBIOTICS USE ON THE SAFETY OF HELICOBACTER PYLORI TREATMENTS: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

HELICOBACTER PYLORI PROMOTES DNA DAMAGE AND INHIBITS TUMOR PROLIFERATION AND MIGRATION THROUGH THE ACVR1-IRF3-POLD1 SIGNALING AXIS
HELICOBACTER PYLORI PROMOTES DNA DAMAGE AND INHIBITS TUMOR PROLIFERATION AND MIGRATION THROUGH THE ACVR1-IRF3-POLD1 SIGNALING AXIS

EFFECTIVENESS OF HELICOBACTER PYLORI TREATMENTS ACCORDING TO ANTIBIOTIC RESISTANCE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF HELICOBACTER PYLORI TREATMENTS ACCORDING TO ANTIBIOTIC RESISTANCE: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Item 1 - 10 / 10
1